HBIO · Harvard Bioscience Inc
$6.10
+0.02 (+0.25%)
At close · Jul 27
Going-concern doubt
— cleared May 12, 2026
The latest filing states the doubt was alleviated.
“Management has evaluated the Company's ability to continue as a going concern under ASC 205-40 for the twelve months following the issuance of these financial statements and concluded that the conditions and events that initially raised substantial doubt have been alleviated and that substantial doubt does not exist as of the date of issuance.”View the 10-Q filed May 12, 2026
Market Cap
$27.06M
Shares
4.51M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$86.55M
-8.1%
FY2025
Net Income
-$56.7M
-357.1%
FY2025
Gross Margin
57.67%
-0.5pp
FY2025
Operating Margin
-56.13%
-49.5pp
FY2025
Diluted EPS
-$12.80
-357.1%
FY2025
Operating Cash Flow
$6.73M
+367.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $85.53M | $86.55M | $94.14M | $112.25M | $113.34M | $118.9M | $102.1M | $116.18M | $120.77M | $77.41M | $104.52M | $108.66M | $108.66M | $105.17M | $111.17M | $108.86M | $108.18M | $85.77M | |
| $35.56M | $36.64M | $39.37M | $46.18M | $52.52M | $51.25M | $44.06M | $51.85M | $57.59M | $38.24M | $56.11M | $59.94M | $59.32M | $57.48M | $58.83M | $58.67M | $56.37M | $44.09M | |
| $49.97M | $49.91M | $54.77M | $66.07M | $60.82M | $67.65M | $58.04M | $64.32M | $63.18M | $39.17M | $48.42M | $48.72M | $49.34M | $47.7M | $52.34M | $50.19M | $51.81M | $41.68M | |
| — | 57.67% | 58.18% | 58.86% | 53.66% | 56.9% | 56.85% | 55.37% | 52.31% | 50.6% | 46.32% | 44.84% | 45.41% | 45.35% | 47.08% | 46.11% | 47.89% | 48.6% | |
| $8.83M | $8.83M | $10.41M | $11.76M | $12.33M | $10.8M | $8.69M | $10.72M | $10.99M | $5.65M | $5.39M | $6.42M | $4.88M | $4.15M | $4.34M | $3.87M | $4.67M | $4.4M | |
| $19.58M | $19.22M | $22.21M | $24.06M | $25.04M | $24.64M | $19.92M | $23.26M | $24.44M | $15.08M | $20.49M | $20.58M | $18.23M | $17.33M | $18.29M | $16.91M | $16.38M | $11.76M | |
| $17.26M | $17.74M | $21.49M | $22.76M | $24.49M | $24.31M | $23.51M | $22.76M | $21.38M | $17.53M | $20.95M | $19.83M | $16.83M | $17.89M | $18.12M | $17.63M | $17.67M | $15.11M | |
| $3.69M | $4.03M | $5.26M | $5.53M | $6.12M | $5.84M | $5.71M | $5.75M | $5.38M | $1.55M | $2.72M | $2.82M | $2.58M | $2.59M | $2.75M | $2.75M | $2.36M | $1.84M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $4.21M | $4.33M | $3.92M | — | |
| $342K | $200K | $800K | $391K | $2.39M | $1.28M | $2.03M | $1.35M | — | $0 | -$4000 | $788K | $1.03M | $2.15M | $310K | $467K | $498K | $516K | |
| $50.06M | $98.49M | $60.98M | $64.18M | $67.75M | $65.59M | $57.82M | $63.95M | $62.2M | $39.81M | $51.41M | $50.44M | $42.73M | $46.16M | $44.51M | $41.79M | $41.59M | $33.63M | |
| -$86K | -$48.58M | -$6.21M | $1.89M | -$6.93M | $2.07M | $221K | $377K | $984K | -$635K | -$3M | -$1.71M | $6.62M | $1.54M | $7.83M | $8.41M | $10.22M | $8.06M | |
| — | -56.13% | -6.6% | 1.69% | -6.12% | 1.74% | 0.22% | 0.32% | 0.81% | -0.82% | -2.87% | -1.58% | 6.09% | 1.46% | 7.04% | 7.72% | 9.45% | 9.39% | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $12.04M | $12.73M | $14.14M | — | |
| $5.66M | — | — | — | — | — | — | — | $5.37M | $713K | $639K | $846K | $990K | $955K | $584K | $752K | $677K | $277K | |
| -$9.81M | -$8.81M | -$5.45M | -$4.45M | -$2.25M | -$2.21M | -$7.51M | -$5.88M | -$8.96M | -$1.99M | -$81K | -$1.9M | -$2.2M | -$1.1M | -$938K | -$1.54M | -$655K | $1.76M | |
| -$9.9M | -$57.39M | -$11.67M | -$2.56M | -$9.18M | -$140K | -$7.29M | -$5.5M | -$7.98M | -$2.62M | -$3.08M | -$3.61M | $4.42M | $435K | $6.89M | $6.87M | $9.56M | $9.81M | |
| -$115K | -$686K | $740K | $859K | $337K | $148K | $518K | -$815K | -$3.68M | -$605K | $1.23M | $15.43M | $2.06M | -$288K | $2.4M | $1.58M | -$9.45M | $2.67M | |
| -$9.78M | -$56.7M | -$12.41M | -$3.42M | -$9.52M | -$288K | -$7.81M | -$4.69M | -$2.92M | -$865K | -$4.31M | -$19.04M | $2.36M | -$1.83M | $2.37M | $3.81M | $19.02M | $7.23M | |
| — | -65.51% | -13.18% | -3.04% | -8.4% | -0.24% | -7.65% | -4.03% | -2.42% | -1.12% | -4.12% | -17.52% | 2.17% | -1.74% | 2.13% | 3.5% | 17.58% | 8.43% | |
| -$7.74M | -$52.7M | -$13.89M | -$2.55M | -$14.54M | $2.75M | -$8.19M | -$3.84M | -$5.78M | $5.12M | -$9.08M | -$22.69M | -$3.23M | $389K | $3.23M | $1.99M | $16.95M | $8.16M | |
| USD/shares | — | -$12.80 | -$2.80 | -$0.80 | -$2.30 | -$0.10 | — | -$1.20 | -$0.80 | -$0.20 | -$1.30 | -$5.70 | $0.70 | -$0.60 | $0.90 | $1.40 | $6.60 | $2.40 |
| USD/shares | — | -$12.80 | -$2.80 | -$0.80 | -$2.30 | — | — | -$1.20 | -$0.80 | -$0.20 | -$1.30 | -$5.70 | $0.70 | -$0.60 | $0.80 | $1.30 | $6.50 | $2.40 |
| shares | — | 4.44M | 4.35M | 4.24M | 4.14M | 4.03M | 3.86M | 3.78M | 3.65M | 3.48M | 3.42M | 3.36M | 3.22M | 3.04M | 2.88M | 2.85M | 2.9M | 2.96M |
| shares | — | 4.44M | 4.35M | 4.24M | 4.14M | 4.03M | 3.86M | 3.78M | 3.65M | 3.48M | 3.42M | 3.36M | 3.32M | 3.19M | 2.98M | 2.98M | 2.94M | 2.99M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.66×
Peer median 1.28×
EV/EBIT
—
P/E (TTM)
—
Peer median 17.58×
Peer medians compare against the 18 similar-size Medical Instruments & Supplies companies (of 50 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| United States | $38,966,000 | $41,738,000 | $48,205,000 | $49,912,000 | $49,831,000 | $42,054,000 | — |
| EMEA | $26,710,000 | $28,405,000 | $33,275,000 | — | — | — | — |
| China | $10,969,000 | $13,297,000 | — | — | — | $23,884,000 | — |
| Asia Other | $6,678,000 | $7,099,000 | $8,765,000 | — | — | — | — |
| Americas Other | $3,227,000 | $3,596,000 | $3,517,000 | — | — | — | — |
| United Kingdom | — | — | — | — | — | — | $116,176,000 |
| Greater China | — | — | $18,488,000 | $16,393,000 | $13,496,000 | — | — |
| Rest of the World | — | — | — | $16,343,000 | $19,810,000 | $6,224,000 | — |
| Europe | — | — | — | $30,687,000 | $35,767,000 | $29,938,000 | — |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Instruments, Equipment, Software and Accessories | $78,260,000 | $86,964,000 | $105,716,000 | $108,165,000 | $114,115,000 | $97,473,000 | $110,220,000 |
| Service Maintenance and Warranty Contracts | $8,290,000 | $7,171,000 | $6,534,000 | $5,170,000 | $4,789,000 | $4,627,000 | $5,956,000 |